| - GRCh37:
- Chr14:21162091
- GRCh38:
- Chr14:20693932
| ANG, EGILA, RNASE4 | G123E | Amyotrophic lateral sclerosis type 9 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21161947
- GRCh38:
- Chr14:20693788
| ANG, EGILA, RNASE4 | R75H | not provided, Amyotrophic lateral sclerosis type 9 | Uncertain significance (Feb 25, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:21161785
- GRCh38:
- Chr14:20693626
| ANG, EGILA, RNASE4 | P21L | Amyotrophic lateral sclerosis type 9, not provided | Uncertain significance (Jan 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:21161785
- GRCh38:
- Chr14:20693626
| ANG, EGILA, RNASE4 | P21Q | Amyotrophic lateral sclerosis type 9, not provided | Benign/Likely benign (Apr 20, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:21161761
- GRCh38:
- Chr14:20693602
| ANG, EGILA, RNASE4 | V13A | Amyotrophic lateral sclerosis type 9 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21161702
- GRCh38:
- Chr14:20693543
| ANG, EGILA, RNASE4 | | Amyotrophic lateral sclerosis type 9 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21152768
- GRCh38:
- Chr14:20684609
| ANG, RNASE4 | | Amyotrophic lateral sclerosis type 9 | Uncertain significance (Apr 27, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21162306
- GRCh38:
- Chr14:20694147
| ANG, EGILA, RNASE4 | | Amyotrophic lateral sclerosis type 9 | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21162248
- GRCh38:
- Chr14:20694089
| ANG, EGILA, RNASE4 | | Amyotrophic lateral sclerosis type 9 | Uncertain significance (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21152394
- GRCh38:
- Chr14:20684235
| ANG | | Amyotrophic lateral sclerosis type 9 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21161726
- GRCh38:
- Chr14:20693567
| ANG, EGILA, RNASE4 | M1I | ANG-related condition, Amyotrophic lateral sclerosis type 10, not provided, Amyotrophic lateral sclerosis type 9 | Conflicting interpretations of pathogenicity (Oct 21, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr14:21162177
- GRCh38:
- Chr14:20694018
| ANG, EGILA, RNASE4 | | Amyotrophic lateral sclerosis type 9 | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21162164
- GRCh38:
- Chr14:20694005
| ANG, EGILA, RNASE4 | | Amyotrophic lateral sclerosis type 9 | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21162088
- GRCh38:
- Chr14:20693929
| ANG, EGILA, RNASE4 | A122V | Amyotrophic lateral sclerosis type 9 | Likely benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21162086
- GRCh38:
- Chr14:20693927
| ANG, EGILA, RNASE4 | | Amyotrophic lateral sclerosis type 9, not provided | Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:21161973
- GRCh38:
- Chr14:20693814
| ANG, EGILA, RNASE4 | K84E | not specified, Amyotrophic lateral sclerosis type 9, not provided
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:21161822
- GRCh38:
- Chr14:20693663
| RNASE4, ANG, EGILA | | Amyotrophic lateral sclerosis type 9, Inborn genetic diseases, not provided
| Benign/Likely benign (Oct 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:21152928
- GRCh38:
- Chr14:20684769
| ANG, LOC130055270, RNASE4 | | Amyotrophic lateral sclerosis type 9 | Likely benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21152895
- GRCh38:
- Chr14:20684736
| ANG, LOC130055270, RNASE4 | | Amyotrophic lateral sclerosis type 9 | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21152821
- GRCh38:
- Chr14:20684662
| ANG, RNASE4 | | Amyotrophic lateral sclerosis type 9 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21152699
- GRCh38:
- Chr14:20684540
| ANG | | Amyotrophic lateral sclerosis type 9 | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21152604
- GRCh38:
- Chr14:20684445
| ANG, LOC130055269 | | Amyotrophic lateral sclerosis type 9 | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21152555
- GRCh38:
- Chr14:20684396
| LOC130055269, ANG | | Amyotrophic lateral sclerosis type 9 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21152553
- GRCh38:
- Chr14:20684394
| ANG, LOC130055269 | | Amyotrophic lateral sclerosis type 9 | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21152535
- GRCh38:
- Chr14:20684376
| ANG, LOC130055269 | | Amyotrophic lateral sclerosis type 9 | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21152513
- GRCh38:
- Chr14:20684354
| ANG | | Amyotrophic lateral sclerosis type 9 | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21152412
- GRCh38:
- Chr14:20684253
| ANG | | Amyotrophic lateral sclerosis type 9 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21152406
- GRCh38:
- Chr14:20684247
| ANG | | Amyotrophic lateral sclerosis type 9 | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21152402
- GRCh38:
- Chr14:20684243
| ANG | | Amyotrophic lateral sclerosis type 9 | Benign (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21152357
- GRCh38:
- Chr14:20684198
| ANG | | Amyotrophic lateral sclerosis type 9 | Benign (Jan 12, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21152342
- GRCh38:
- Chr14:20684183
| ANG | | Amyotrophic lateral sclerosis type 9 | Uncertain significance (Jan 13, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21162053
- GRCh38:
- Chr14:20693894
| ANG, EGILA, RNASE4 | | Inborn genetic diseases, Amyotrophic lateral sclerosis type 9, not specified, not provided | Benign/Likely benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr14:21162132
- GRCh38:
- Chr14:20693973
| ANG, EGILA, RNASE4 | V137I | Amyotrophic lateral sclerosis type 9 | Pathogenic (Feb 1, 2008) | no assertion criteria provided |
| - GRCh37:
- Chr14:21162130
- GRCh38:
- Chr14:20693971
| ANG, EGILA, RNASE4 | P136L | ANG-related condition, Amyotrophic lateral sclerosis type 9 | Conflicting interpretations of pathogenicity (Aug 6, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr14:21161878
- GRCh38:
- Chr14:20693719
| ANG, EGILA, RNASE4 | S52N | Amyotrophic lateral sclerosis type 9 | Likely pathogenic (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr14:21161931
- GRCh38:
- Chr14:20693772
| ANG, EGILA, RNASE4 | I70V | not specified, not provided, Amyotrophic lateral sclerosis type 9
| Conflicting interpretations of pathogenicity (Oct 9, 2022) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr14:21161914
- GRCh38:
- Chr14:20693755
| ANG, EGILA, RNASE4 | K64I | Amyotrophic lateral sclerosis type 9 | Pathogenic (Apr 1, 2006) | no assertion criteria provided |
| - GRCh37:
- Chr14:21161912
- GRCh38:
- Chr14:20693753
| ANG, EGILA, RNASE4 | C63W | Amyotrophic lateral sclerosis type 9 | Pathogenic (Apr 1, 2006) | no assertion criteria provided |
| - GRCh37:
- Chr14:21161887
- GRCh38:
- Chr14:20693728
| ANG, EGILA, RNASE4 | R55K | Amyotrophic lateral sclerosis type 9 | Pathogenic (Apr 1, 2006) | no assertion criteria provided |
| - GRCh37:
- Chr14:21161844
- GRCh38:
- Chr14:20693685
| ANG, EGILA, RNASE4 | K41E | Amyotrophic lateral sclerosis type 9 | Pathogenic (Apr 1, 2006) | no assertion criteria provided |
| - GRCh37:
- Chr14:21161845
- GRCh38:
- Chr14:20693686
| ANG, EGILA, RNASE4 | K41I | not specified, not provided, Amyotrophic lateral sclerosis type 9
| Conflicting interpretations of pathogenicity (Oct 1, 2023) | criteria provided, conflicting interpretations |
| - GRCh37:
- Chr14:21161830
- GRCh38:
- Chr14:20693671
| ANG, EGILA, RNASE4 | Q36L | Amyotrophic lateral sclerosis type 9 | Pathogenic (Apr 1, 2006) | no assertion criteria provided |